GCP Monitoring Battlecards
Use concise battlecard responses to handle common objections to risk-based clinical monitoring escalation.
The routine visit is next week. A safety or endpoint signal appears before the scheduled monitoring visit. Your line Routine timing does not control escalation; critical-to-quality impact does. If the signal can affect safety or endpoint reliability before next week, we act now. Waiting because the calendar already has a visit. It respects the monitoring plan while clarifying that risk signals can change oversight timing. The CRO owns that issue. A delegated activity affects critical trial data. The CRO may own the task and vendor follow-up, but the sponsor owns the quality decision. Let's document impact, owner, due time, and…
Sign up free — one personalized lesson every day, matched to your role and goals.
Already have an account? Sign in